Active, Not Recruiting
Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC
NCT03410615
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- University Hospital of Antwerp Edegem, Belgium
- University Hospital of Gent Ghent, Belgium
- University Hospital Leuven Leuven, Belgium